Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q793I8

Entry ID Method Resolution Chain Position Source
6L9U X-ray 260 A A 1-184 PDB
6L9V X-ray 305 A A/B/C/D 1-184 PDB
6L9W X-ray 290 A A/B/C/D/E/F 1-184 PDB
AF-Q793I8-F1 Predicted AlphaFoldDB

14 variants for Q793I8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388667045 5 E>D No EVA
rs3393562819 13 V>* No EVA
rs3388663113 52 N>Y No EVA
rs3388651097 65 V>M No EVA
rs261057523 68 I>V No EVA
rs36755141 82 V>I No EVA
rs47600032 94 T>I No EVA
rs3388667075 136 S>T No EVA
rs3388666176 146 R>G No EVA
rs3388660931 153 N>Y No EVA
rs3388660955 154 W>C No EVA
rs3388663037 154 W>S No EVA
rs3388652207 173 R>S No EVA
rs3388662057 174 S>G No EVA

No associated diseases with Q793I8

1 regional properties for Q793I8

Type Name Position InterPro Accession
domain Forkhead-associated (FHA) domain 47 - 120 IPR000253

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Colocalizes with lysosomal marker LAMP2 following homooligomerization and subsequent activation
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

5 GO annotations of biological process

Name Definition
cytoplasmic pattern recognition receptor signaling pathway The series of molecular signals initiated by a ligand binding to a cytoplasmic pattern recognition receptor (PRR). PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species.
I-kappaB kinase/NF-kappaB signaling The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
positive regulation of I-kappaB kinase/NF-kappaB signaling Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
protein homooligomerization The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A2VDM0 TIFA TRAF-interacting protein with FHA domain-containing protein A Bos taurus (Bovine) PR
Q96CG3 TIFA TRAF-interacting protein with FHA domain-containing protein A Homo sapiens (Human) PR
Q5XIB9 Tifa TRAF-interacting protein with FHA domain-containing protein A Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MSTFEDADTE ETVTCLQMTI YHPGQQSGIF KSIRFCSKEK FPSIEVVKFG RNSNMCQYTF
70 80 90 100 110 120
QDKQVSRIQF VLQPFKQFNS SVLSFEIKNM SKKTSLMVDN QELGYLNKMD LPYKCMLRFG
130 140 150 160 170 180
EYQFLLQKED GESVESFETQ FIMSSRPLLQ ENNWPTQNPI PEDGMYSSYF THRSSPSEMD
ENEL